Business registries · firm from USPTO records
Bristol-Myers Squibb Company
- Place
- 345 Park Avenue, New York, NY
- Entity type
- Corporation
- State of organization
- DE (as the owner states it in trademark filings)
- Patents
- 4 granted 1953-04-30 to 2022-11-23
- Trademarks
- 2,608, 250 live
- Record
- EXACT high confidence: identical full name and state
- State business registration
- BRISTOL-MYERS SQUIBB COMPANY EXACT high confidence: identical full name and state
- Federal lobbying client
- BRISTOL-MYERS SQUIBB COMPANY EXACT high confidence: identical full name and state
- Source
- USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place
Patents
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12770378 | Medical imaging analysis using self-supervised learning | 2026-10-20 | PTBLXML, file of 2026-10-20 |
| US 12767721 | CD40 antagonist antibody variants with improved pharmacokinetic properties | 2026-10-20 | PTBLXML, file of 2026-10-20 |
| US 12767654 | 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-indol-5-yl)piperidin-1-yl)acetamide salt and crystalline forms thereof | 2026-10-20 | PTBLXML, file of 2026-10-20 |
| US 12760046 | Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compounds | 2026-10-13 | PTBLXML, file of 2026-10-13 |
| US 12760029 | KRAS G12D inhibitors | 2026-10-13 | PTBLXML, file of 2026-10-13 |
| US 12759999 | Indole carboxamide compounds | 2026-10-13 | PTBLXML, file of 2026-10-13 |
| US 12758709 | Drug cartridge, drug delivery device, and methods for preparing thereof | 2026-10-13 | PTBLXML, file of 2026-10-13 |
| US 12758559 | RXFP1 agonists | 2026-10-13 | PTBLXML, file of 2026-10-13 |
| US 12751948 | Dosage forms for TYK2 inhibitors | 2026-10-06 | PTBLXML, file of 2026-10-06 |
| US 12747296 | Anti-CCR8 antibodies for treating cancer | 2026-09-29 | PTBLXML, file of 2026-09-29 |
| US 12735488 | Antibodies binding to vista at acidic pH | 2026-09-15 | PTBLXML, file of 2026-09-15 |
| US 12734169 | Dosage forms for Tyk2 inhibitors | 2026-09-15 | PTBLXML, file of 2026-09-15 |
| US 12723041 | Lactone and lactam containing compounds useful as immunomodulators | 2026-09-01 | PTBLXML, file of 2026-09-01 |
| US 12715856 | Compounds useful as immunomodulators | 2026-08-25 | PTBLXML, file of 2026-08-25 |
| US 12714778 | Drug cartridge, drug delivery devices, and methods for preparing thereof | 2026-08-25 | PTBLXML, file of 2026-08-25 |
| US 12709594 | RXFP1 agonists | 2026-08-18 | PTBLXML, file of 2026-08-18 |
| US 12699097 | M-protein assays | 2026-08-04 | PTBLXML, file of 2026-08-04 |
| US 12686716 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | 2026-07-21 | PTBLXML, file of 2026-07-21 |
| US 12680108 | Miniaturized dystrophins and uses thereof | 2026-07-14 | PTBLXML, file of 2026-07-14 |
| US 12679823 | Oxopyrrolidine FPR2 agonists | 2026-07-14 | PTBLXML, file of 2026-07-14 |
| US 12673954 | Benzofuran compounds as sting agonists | 2026-07-07 | PTBLXML, file of 2026-07-07 |
| US 12673042 | [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds | 2026-07-07 | PTBLXML, file of 2026-07-07 |
| US 12668598 | MK2 inhibitors and uses thereof | 2026-06-30 | PTBLXML, file of 2026-06-30 |
| US 12639333 | Indicating differences in and reconciling data stored in disparate data storage devices | 2026-05-26 | PTBLXML, file of 2026-05-26 |
| US 12637522 | Monoclonal antibodies against BCMA | 2026-05-26 | PTBLXML, file of 2026-05-26 |
Trademarks
| Mark | Serial | Filed | Status | Classes | Source |
|---|---|---|---|---|---|
| OPDIVO SCVANTAGE | 97690377 | 2022-11-23 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| OPDIVO SCFREA | 97690376 | 2022-11-23 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| OPDIVO SQFREA | 97690372 | 2022-11-23 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| OPDIVO EZQU | 97690369 | 2022-11-23 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| OPDIVO SCVANTIG | 97690368 | 2022-11-23 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| EZSC | 97690367 | 2022-11-23 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| OPDIVO EZSC | 97690365 | 2022-11-23 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| ADMINVA | 97690358 | 2022-11-23 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| QFRIA | 97690355 | 2022-11-23 | Pending application | 005 | TRTDXFAP, file of 2026-09-10 |
| OPDIVO SQVANTIG | 97690352 | 2022-11-23 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| COMJEXO | 97566260 | 2022-08-26 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| IQ-JEX | 97566258 | 2022-08-26 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| QSELF | 97566255 | 2022-08-26 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| QSELFA | 97566254 | 2022-08-26 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| SELFQ | 97566247 | 2022-08-26 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| SIMPLICUE | 97566246 | 2022-08-26 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| HAVENISC | 97566242 | 2022-08-26 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| HYJURNY | 97566239 | 2022-08-26 | Abandoned | 005 | TRTDXFAP, file of 2026-10-06 |
| HYOPZIG | 97566236 | 2022-08-26 | Abandoned | 005 | TRTDXFAP, file of 2026-10-06 |
| HYVANU | 97566232 | 2022-08-26 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| MYTIRMA | 97566228 | 2022-08-26 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| OPLIFIDE | 97566225 | 2022-08-26 | Abandoned | 005 | TRTYRAP, file of 2026-04-03 |
| QUHYO | 97566220 | 2022-08-26 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| QVANTIG | 97566219 | 2022-08-26 | Registered | 005 | TRTYRAP, file of 2026-04-03 |
| SURHYLA | 97566215 | 2022-08-26 | Abandoned | 005 | TRTDXFAP, file of 2026-10-06 |
The newest 25 of 2,608. All marks of this owner
Possible related entities
No other firm on file at the same street address.
Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.